Anti-RSV Antibody, glycoprotein, all type A, B strains, clone 131-2G

RSV is a labile paramyxovirus that produces a characteristic fusion of human cells in tissue culture--the syncytial effect. Two subtypes, A and B, have been identified. Subtype B are characterized as the asymptomatic strains of the virus. The more severe clinical illnesses involve Subtype A strains.

Respiratory Syncytial virus A2

ELISA, Indirect Immunofluorescence

Final working dilutions must be determined by end user.

Optimal working dilutions must be determined by the end user.

Research Category
Infectious Diseases

Research Sub Category
Infectious Diseases - Viral

This Anti-RSV Antibody, glycoprotein, all type A, B strains, clone 131-2G is validated for use in ELISA, IF for the detection of Respiratory Syncytial Virus.

Glycoprotein, 89 kD. Recognizes both A and B strains.

Purified, FITC conjugated. Liquid 0.02MPB, 0.25M NaCl, 0.1% sodium azide

Store at 2-8ºC

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.